HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shisheng Wang Selected Research

Glycopeptides

8/2020Characterization of N-linked intact glycopeptide signatures of plasma IgGs from patients with prostate carcinoma and benign prostatic hyperplasia for diagnosis pre-stratification.
1/2020Comparative Glycoproteomic Profiling of Human Body Fluid between Healthy Controls and Patients with Papillary Thyroid Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shisheng Wang Research Topics

Disease

17Neoplasms (Cancer)
01/2023 - 02/2016
5Breast Neoplasms (Breast Cancer)
01/2023 - 12/2015
5Pancreatic Neoplasms (Pancreatic Cancer)
11/2022 - 01/2018
4Hypoxia (Hypoxemia)
11/2021 - 01/2019
3Fibrosis (Cirrhosis)
01/2024 - 01/2021
3Pancreatitis
08/2023 - 05/2021
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 12/2017
3Lung Neoplasms (Lung Cancer)
01/2022 - 11/2016
2Inflammation (Inflammations)
08/2023 - 11/2016
2Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 01/2021
2Infections
12/2022 - 01/2021
2Neoplasm Metastasis (Metastasis)
10/2022 - 10/2021
2Carcinoma (Carcinomatosis)
01/2022 - 08/2020
2Mitochondrial Diseases (Mitochondrial Disease)
01/2021 - 11/2020
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2024
1Necrosis
08/2023
1Acute Coronary Syndrome
04/2023
1Type 2 Diabetes Mellitus (MODY)
01/2023
1Myocardial Infarction
07/2022
1Cardiovascular Diseases (Cardiovascular Disease)
07/2022
1Fatty Liver
06/2022
1Brain Injuries (Brain Injury)
01/2022
1Brain Infarction
01/2022
1Neurofibromatosis 1 (Neurofibromatosis Type I)
01/2022
1Ischemic Stroke
01/2022
1Immune System Diseases (Immune Disorders)
08/2020
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
08/2020
1Thyroiditis
01/2020

Drug/Important Bio-Agent (IBA)

8Oleanolic AcidIBA
11/2022 - 12/2015
5Proteins (Proteins, Gene)FDA Link
01/2023 - 02/2016
4ProteomeIBA
01/2023 - 10/2020
3Biomarkers (Surrogate Marker)IBA
01/2024 - 01/2020
3K73-03IBA
11/2022 - 11/2020
3Antineoplastic Agents (Antineoplastics)IBA
11/2021 - 12/2015
32- morpholinomethyl- 3- oxoolean- 12- en- 28- oic acidIBA
01/2018 - 01/2016
3SZC017IBA
12/2017 - 12/2015
2Death Domain ReceptorsIBA
01/2023 - 01/2021
2Therapeutic UsesIBA
01/2023 - 11/2021
24- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA
12/2022 - 01/2022
2Glycoproteins (Glycoprotein)IBA
06/2022 - 01/2020
21-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2021 - 01/2021
2Photosensitizing Agents (Photosensitizers)IBA
11/2021 - 01/2021
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2021 - 10/2021
2Kazal Pancreatic Trypsin InhibitorIBA
10/2021 - 11/2020
2GlycopeptidesIBA
08/2020 - 01/2020
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2024
1Radioactive TracersIBA
01/2024
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
01/2024
1Gallium-68IBA
01/2024
1Carbon Tetrachloride (Tetrachloromethane)IBA
01/2024
1EnzymesIBA
08/2023
1Methylmalonyl-CoA carboxytransferaseIBA
08/2023
1OrnithineIBA
08/2023
1LDL Lipoproteins (beta Lipoproteins)IBA
04/2023
1Proprotein Convertase 9IBA
04/2023
1oxidized low density lipoproteinIBA
04/2023
1CeruletideIBA
04/2023
1OxidesIBA
01/2023
1Bortezomib (Velcade)FDA Link
01/2023
1BiguanidesIBA
01/2023
1LigandsIBA
01/2023
1Liposomes (Liposome)IBA
01/2023
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2023
1Metformin (Glucophage)FDA LinkGeneric
01/2023
1IntegrinsIBA
10/2022
1AflatoxinsIBA
10/2022
1shexiang baoxinIBA
07/2022
1Ceruloplasmin (Ferroxidase)IBA
06/2022
1C-Reactive ProteinIBA
06/2022
1Triglycerides (Triacylglycerol)IBA
06/2022
1Glucose (Dextrose)FDA LinkGeneric
06/2022
1bis(p-chlorophenyl)acetic acid (DDA)IBA
01/2022
1Myosin Light Chains (Myosin Essential Light Chain)IBA
01/2022
1Protein Kinase CIBA
01/2022
1rottlerinIBA
01/2022
1pevonedistatIBA
01/2022
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
01/2022
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2022
1Myristoylated Alanine-Rich C Kinase SubstrateIBA
01/2022
1Cullin Proteins (Cullins)IBA
01/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2021
1Oxygen (Dioxygen)IBA
11/2021
1Messenger RNA (mRNA)IBA
11/2021
1Indicators and Reagents (Reagents)IBA
10/2021
1Epidermal Growth Factor (EGF)IBA
10/2021
1GemcitabineFDA Link
10/2021
1Amino AcidsFDA Link
09/2021
1taurolithocholic acid 3-sulfate (TLC-S)IBA
05/2021
1InterleukinsIBA
01/2021
1ErbB Receptors (EGF Receptor)IBA
01/2021
1Cisplatin (Platino)FDA LinkGeneric
01/2021
1CytokinesIBA
01/2021
1Polysaccharides (Glycans)IBA
01/2021
1VaccinesIBA
01/2021
1InflammasomesIBA
01/2021
1Immunoglobulins (Immunoglobulin)IBA
08/2020
1(R,S)- 4- ((4'- methoxy- 4- (methyl)- 3- ((4- methoxyphenyl)ethynyl)biphenyl- 2- yl)(4- methoxyphenyl)methylene)- 2,5- cyclohexadien- 1- one,IBA
01/2020
1Alkynes (Acetylenes)IBA
04/2019

Therapy/Procedure

10Therapeutics
01/2023 - 12/2017
2Photochemotherapy (Photodynamic Therapy)
11/2021 - 01/2021